Navigation Links
Endo Pharmaceuticals to Present at Cowen & Co. 32nd Annual Health Care Conference
Date:2/22/2012

CHADDS FORD, Pa., Feb. 22, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the Cowen & Co. 32nd Annual Heath Care Conference on Wednesday, March 7, 2012 at 10:40 a.m. ET.  The conference will be held at the Boston Marriott Copley Place in Boston, MA.

A live webcast and audio archive of the presentation will be available on the company's website at http://www.endo.com/.  Click on Investor Relations, and then the link to the Event and Presentation.  Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Endo

Endo Pharmaceuticals Holdings is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments - branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals Holdings and its businesses American Medical Systems, HealthTronics and Qualitest Pharmaceuticals, please visit http://www.endo.com/.


'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  ConvaTec, a privately-held medical ... Clerkin has been appointed chief financial officer of ... Clerkin was previously executive vice president and chief financial ... -based biotechnology company.  Mr. Clerkin was part of a ... Elan, culminating in its sale to Perrigo, a pharmaceutical ...
(Date:7/22/2014)... 2014 The steady decline of pharmaceutical ... previously rep-friendly specialties, according to the spring 2014 ... firm ZS Associates.      AccessMonitor™ aggregates ... sales teams. The report examines how often approximately ... pharmaceutical sales reps who visit their offices. ...
(Date:7/22/2014)... 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... outsourcing company with operations in China ... that it will release financial results for the second quarter ... Wednesday, August 13, 2014 (which will be Thursday morning, August ... on the investor relations section of the Company,s website at ...
Breaking Medicine Technology:ConvaTec Names Nigel Clerkin Chief Financial Officer 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2
... 10, 2011 USANA Health Sciences, Inc. (NYSE: ... nutritional gaps are common in the average American diet and ... those gaps.  However, USANA scientists and advising physicians caution that ... Dietary Guidelines for Americans, 2010 and ...
... MATEO, Calif., Feb. 10, 2011 AlphaDetail, a leader ... biotech industries, reported a 30% increase in revenue in ... time in the company,s history. "Our clients ... provides the marketing research solutions that get at the ...
Cached Medicine Technology:USDA Recognizes Benefit of Supplements in New Dietary Guidelines But Doesn't Go Far Enough 2AlphaDetail Revenue Soars 30% in 2010 2
(Date:7/22/2014)... July 22, 2014 Alan Tonelson of ... young child. While most kids outgrow the inhibiting speech ... He is among the three million people in the ... mild to severe. Throughout his youth, he participated in ... sessions and visits with private speech-and-language pathologists. None helped ...
(Date:7/22/2014)... "The Big Secrets: Ten Things Every Young Person Should Know ... young people can read. , But be careful! What’s in this ... people have been living with all their lives. And If the ... sex to death, this self-help book deals directly with social reality ... it like it is. , Tune in to “The Big Secrets” ...
(Date:7/22/2014)... 2014 One woman who looked at diet ... 20 pounds. Unfortunately, the weight loss came at a price ... of her time using the pill, and says her personality ... and insomnia as a result of the caffeine content of ... the age of 37 because of a diet pill she ...
(Date:7/22/2014)... Industry-leading health business information publisher Atlantic Information Services ... Pharmacy Trends and Strategies: 2014 , the latest edition ... of the current state of the specialty pharmacy industry. ... , Specialty drugs on the exchanges ... details of coinsurance levels by plan, by metal tier ...
(Date:7/22/2014)... Cumberland Pediatric Dentistry and Orthodontics stresses ... anxiety-free dental care for children, while maintaining the most ... care. , The orthodontic team is committed to ... adults and those with special needs. Whether a child ... unique care, such as cleft palate, Cumberland Pediatric Dentistry ...
Breaking Medicine News(10 mins):Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 2Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 3Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 4Health News:Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why” 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2Health News:Latest Edition of Annual Book Provides Comprehensive Overview of the Specialty Pharmacy Arena 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 3
... new study published in the journal, Molecular Psychiatry suggested that ... susceptible to sleepwalking. Sleepwalking is a complex disorder and affects ... cent of adults. Though the condition is harmless, it may ... to others. Scientists examined a family of genes known as ...
... called C150T transition in people over 100 years old, a ... mutation was found in the mitochondrial DNA of white blood ... centenarians. The researchers found that 17 per cent of the ... 3.4 per cent of 117 control subjects under the age// ...
... all newly-diagnosed lung cancer cases. Smoking inflicts serious damage to ... quit, as it takes time for the tissue to recover. ... in the form of loss of a gene that could ... Texas have now shown that a close chemical relative of ...
... of the National Academy of Science, recently published a study ... that a brain protein called WAVE-1 may play a key ... found throughout the brain and plays an important role in ... that were produced, without the WAVE-1// protein, by the researchers ...
... by Juliette van den Dolder at the University of Nijmegen ... bone fractures with the help of specially prepared titanium mesh ... into a bone fracture in a rat. They allowed bone ... bone growth being stimulated by the bone// marrow cells. They ...
... it is no term to be happy about, because this ... could affect those individuals whose work or lifestyle demands them ... for a long time without a break could cause blood ... the lungs with possible fatal consequences. This condition is identical ...
Cached Medicine News:Health News:Bones repair themselves with bone marrow cells 2
... Mumps IgG Enzyme- linked Immunosorbent Assay (ELISA) ... determination of IgG antibody to Mumps virus ... be used for the determination of immune ... be used to demonstrate seroconversion or a ...
The DSL-05-10-MUG Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Mumps Virus in human serum. This assay is intended for in...
With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and ste...
... Ultra Laboratory has been uniquely designed ... single facility to integrated networks spanning ... to management reporting and accounts receivable, ... precise laboratory management. All system modules ...
Medicine Products: